Stock Report

Download full stock data and analysis for free Last Updated: 02-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Panchsheel Organics Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: PANCHSHEEL | BSE: 531726

₹116.50

up-down-arrow ₹0.45 (0.39%)

As on 01-Sep-2026IST

Market cap

info icon

₹153 Cr

Revenue (TTM)

info icon

₹108 Cr

P/E Ratio

info icon

14.9

P/B Ratio

info icon

1.1

Div. Yield

info icon

0.7 %

Edit peer-selector-edit
Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Market cap (₹ Cr)
 153 35,015 29,555 17,723 15,518
Revenue (₹ Cr)
 108 9,683 2,372 2,590 1,108
Net Profit (₹ Cr)
 10.30 1,018.97 497.77 603.02 270.18
Net Margin (%)
 9.25 10.47 20.72 22.63 23.29
RoE (%)
 7.38 21.30 28.49 19.61 14.45
Price to Earnings
 14.90 34.62 59.37 29.39 56.35
Price-To-Book
 1.07 6.69 14.62 5.09 7.48

Income Statement (₹ Cr)

Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Operating Revenue arrow
107.79 9,683.45 2,371.81 2,590.40 1,108.39
Total Income arrow
111.26 9,730.84 2,402.61 2,664.23 1,159.90
Total Expenditure arrow
94.74 7,739.53 1,608.91 1,753.71 720.01
EBITDA arrow
13.05 1,943.92 762.90 836.69 388.38
Depreciation arrow
2.42 425.10 98.11 78.88 74.78
EBIT arrow
10.63 1,518.82 664.79 757.81 313.60
Interest arrow
0.30 148.45 26.33 5.43 0.26
Other Income arrow
3.47 47.39 30.80 73.83 51.50
Exceptional Items arrow
0.00 -27.85 0.00 -25.66 -3.28
Profit before Tax arrow
13.79 1,389.91 669.26 800.55 361.56
Provision for Tax arrow
3.49 370.94 171.48 197.53 91.39
Profit after Tax arrow
10.30 1,018.97 497.77 603.02 270.18

Liabilities (₹ Cr)

Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Shareholder's Funds arrow
140.83 4,950.03 1,874.47 3,332.13 2,017.06
Minority Interest arrow
0.00 -7.58 0.00 0.00 2.51
Non-Current Liabilities arrow
4.74 723.57 345.47 142.73 50.51
Current Liabilities arrow
26.36 3,912.24 710.20 508.04 169.08
Total Liabilities arrow
163.28 8,121.73 2,179.88 3,753.59 2,034.25

Assets (₹ Cr)

Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Non-Current Assets arrow
38.44 3,392.16 1,290.62 1,321.38 957.22
Current Assets arrow
89.55 5,612.10 1,483.13 2,649.36 1,250.11
Total Assets arrow
163.28 8,121.73 2,179.88 3,753.59 2,034.25
Total Debt* arrow
5.44 731.70 136.01 0.00 0.38
Net Current Assets arrow
63.19 1,699.86 772.93 2,141.33 1,081.04
Contingent Liabilities arrow
0.77 393.94 8.97 4.82 3.91

Cashflow (₹ Cr)

Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Cash From Operating Activities arrow
3.83 851.71 317.40 391.52 244.52
Cash Flow from Investing Activities arrow
-16.33 -94.00 -298.16 -615.65 -159.99
Cash from Financing Activities arrow
-5.20 -813.96 24.96 -6.23 -98.77
Net Cash Inflow / Outflow arrow
-17.69 -56.25 44.21 -230.35 -14.24

Ratios

Profitability Ratios

 Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
ROCE (%) arrow
13.65 22.49 23.45 25.50 29.62
ROE (%) arrow
7.38 21.30 28.49 19.61 14.45
ROA (%) arrow
6.14 11.42 19.48 16.31 12.66
EBIT Margin (%) arrow
9.86 15.68 28.03 29.25 28.29
Net Margin (%) arrow
9.25 10.47 20.72 22.63 23.29
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Revenue Growth (%) arrow
2.31 18.36 78.33 7.93 -6.72
EBIT Growth (%) arrow
-33.51 30.43 303.07 19.88 -26.64
Net Profit Growth (%) arrow
-23.57 32.39 182.61 21.66 -24.38
EPS Growth (%) arrow
-23.57 36.68 277.72 25.42 -21.99
Book Value Growth (%) arrow
7.06 50.94 18.89 20.94 18.74

Valuation Ratios

 Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Price / Earnings arrow
14.90 33.91 59.37 28.46 55.86
Price / Book Value arrow
1.07 6.69 14.62 5.09 7.48
Dividend Yield (%) arrow
0.69 0.20 0.15 0.35 0.51
EV/EBITDA arrow
11.84 18.56 38.53 20.25 38.88
Market Cap (₹ Cr) arrow
178.01 20,327.45 15,494.53 13,228.83 17,537.35

Solvency Ratios

 Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Debt to Equity arrow
0.00 0.05 0.09 0.00 0.00
Short term debt to equity ratio arrow
0.04 0.11 -- -- 0.00
Current Ratio arrow
3.40 1.43 2.09 5.21 7.39
Quick Ratio arrow
1.69 0.82 1.37 3.85 5.46
Interest Coverage arrow
46.36 10.36 26.41 148.49 1,386.30

Operating Efficiency Ratios

 Panchsheel Organics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Concord Biotech
Debtors to sales (%) arrow
36.41 26.46 22.82 41.42 41.52
Asset Turnover arrow
0.64 1.09 0.93 0.70 0.52
Receivable days arrow
126.46 87.83 85.17 132.12 132.49
Inventory Days arrow
145.45 78.64 90.97 102.08 68.07
Payable days arrow
101.88 174.97 137.94 133.54 123.94
Cash Conversion Cycle arrow
170.03 -8.50 38.21 100.66 76.63
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...